Improving asthma symptom control in rural communities: the design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson study

被引:14
|
作者
Charrois, T
Newman, S
Sin, D
Senthilselvan, A
Tsuyuki, RT
机构
[1] Univ Alberta, EPICORE Ctr, Dept Publ Hlth Sci, Edmonton, AB T6G 2C8, Canada
[2] Univ Alberta, Dept Med, Edmonton, AB, Canada
来源
CONTROLLED CLINICAL TRIALS | 2004年 / 25卷 / 05期
关键词
asthma; outcomes research; pharmacists; patient education; study design; delivery of health care;
D O I
10.1016/j.cct.2004.07.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Methods: The prevalence of asthma in adults in the United States is approximately 7%, and 9% of asthma patients will require hospitalization each year. Many patients do not seek care, as they do not recognize overuse of beta-agonists as a risk factor for poorly controlled asthma. However, pharmacists are able to identify these patients through refill information on reliever medication prescriptions and potentially initiate community-management opportunities for these patients. Design: The study is a randomized, controlled trial. Patients are randomized to intervention or usual care. Study population: Patients are high-risk asthma patients (defined as having an ER visit or hospitalization in the previous year, or using >2 canisters of short-acting beta-agonist in the previous 6 months). They are identified through community pharmacies. Objectives: The primary objective is to determine the effect of an education and referral intervention program initiated by community pharmacists, working with high-risk asthma patients, family physicians and respiratory therapists, on asthma control, as measured by the Asthma Control Questionnaire (ACQ). Secondary objectives include determining the effect of this program on ER visits/hospitalizations, inhaled corticosteroid use, courses of oral steroids and FEV1. Intervention: The intervention includes patient education, assessment and optimization of drug therapy, and physician referral as needed. Patients are referred to a respiratory therapist within 1 week of randomization for measurement of FEV1 and reinforcement of education. Patients assigned to usual care receive written asthma information, referral to a respiratory therapist and usual pharmacy and physician care. Unique aspects: The design of the Better Respiratory Education and Asthma Treatment in Hinton and Edson (BREATHE) study is unique, given the multidisciplinary involvement, rural and community based, pharmacist initiated and targets specifically high risk patients. We believe that this study will show that management of asthma patients, involving the major role-players in their asthma care, will improve their asthma control. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:502 / 514
页数:13
相关论文
共 8 条
  • [1] Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study
    Charrois, Theresa L.
    Newman, Stephen C.
    Senthilselvan, Ambikaipakan
    Tsuyuki, Ross T.
    CANADIAN PHARMACISTS JOURNAL, 2006, 139 (04) : 44 - 50
  • [2] The effect of yoga on respiratory functions, symptom control and life quality of asthma patients: A randomized controlled study
    Turan, Gulcan Bahcecioglu
    Tan, Mehtap
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2020, 38
  • [3] Mother's level of education and knowledge about asthma is a major determinant of asthma control in children: A multicenter study by Respiratory Research Network of India.
    Limaye, Sneha
    Bindusha, Sasidharan
    Haseeb, Mohammed
    Muley, Prasad
    Mujawar, Nilofer
    Ramaswamy, Premalatha
    Kumar, Rajendra
    Bafna, Sanjay
    Dhekne, Jagadish
    Malik, Reyaz
    Bhattacharya, Barnali
    Kulkarni, Suhas
    Madas, Sapna
    Sahasrabudhe, Shruti
    Salvi, Sundeep
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [4] A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate-Severe Asthma
    Garcia, Gabriel
    van Dijkman, Sven C.
    Pavord, Ian
    Singh, Dave
    Oosterholt, Sean
    Fulmali, Sourabh
    Majumdar, Anurita
    Della Pasqua, Oscar
    ADVANCES IN THERAPY, 2024, 41 (08) : 3196 - 3216
  • [5] Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study
    Ortega, Victor E.
    Hawkins, Gregory A.
    Moore, Wendy C.
    Hastie, Annette T.
    Ampleford, Elizabeth J.
    Busse, William W.
    Castro, Mario
    Chardon, Domingo
    Erzurum, Serpil C.
    Israel, Elliot
    Montealegre, Federico
    Wenzel, Sally E.
    Peters, Stephen P.
    Meyers, Deborah A.
    Bleecker, Eugene R.
    LANCET RESPIRATORY MEDICINE, 2014, 2 (03): : 204 - 213
  • [6] A Comprehensive Survey of Healthcare Professionals and Asthma Patients Offering Insight on Current Treatment Gaps and Emerging Device Options (CHOICE) Study: Patient Perception of Symptom Control
    Ostrom, N. K.
    Nathan, R. A.
    Lanier, R.
    Anolik, R.
    Colice, G.
    Marcus, P.
    Schwartz, J.
    Geller, D. E.
    Blaiss, M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB60 - AB60
  • [7] Improvements In Asthma Symptom Control, Quality Of Life, And Perception Of Treatment Effectiveness After Omalizumab Initiation In Adolescents And Adults: Results From A 48-Week, Observational Study
    Carr, T. F.
    Gonzalez-Reyes, E.
    Antonova, E.
    Trzaskoma, B.
    Iqbal, A.
    Limb, S. L.
    Griffin, N. M.
    Lumry, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [8] Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults
    Gold, Diane R.
    Litonjua, Augusto A.
    Carey, Vincent J.
    Manson, Joann E.
    Buring, Julie E.
    Lee, I-Min
    Gordon, David
    Walter, Joseph
    Friedenberg, Georgina
    Hankinson, John L.
    Copeland, Trisha
    Luttinann-Gibson, Heike
    CONTEMPORARY CLINICAL TRIALS, 2016, 47 : 185 - 195